AVP
AVP RAJAPRABARTHINI VATIKA
AVP RAJAPRABARTHINI VATIKA
PACK OF 100 TABLETS
☀️ 6% OFF on ₹600+| Code: 6FESTIVESPECIALOFF
🌍 Buy from our International StoreCouldn't load pickup availability
Product Overview:
AVP Rajapravarthini Vatika is a traditional Ayurvedic herbal-mineral formulation from Arya Vaidya Pharmacy (AVP), prepared for use in women's wellness routines. Its traditional ingredient profile includes Kanya, Kaseesa, Tankana and Ramatha. The formulation is associated with traditional Ayurvedic practices concerning menstrual health. Because menstrual irregularities can have several underlying causes, this product should only be considered with appropriate professional guidance.
Supplement Ingredient:
Kanya, Kaseesa, Tankana, Ramatha
Benefits:
- Traditionally associated with Ayurvedic approaches to Female wellness.
- Contains a combination of herbal and mineral ingredients used in classical formulations.
- Offers a tablet format for use under qualified professional supervision.
How to Use:
The supplied directions mention 1–2 tablets once or twice daily with lukewarm water. However, do not follow cycle-based timing or dosage without confirmation from the product label and a qualified healthcare professional.
Safety Information:
- This formulation contains mineral ingredients, including Kaseesa and Tankana.
- Do not self-prescribe or exceed the recommended dose.
- Do not use it to induce menstruation without medical advice.
FAQs:
Q1. What is AVP Rajapravarthini Vatika?
It is a traditional Ayurvedic herbal-mineral tablet associated with women's menstrual wellness.
Q2. How should Rajapravarthini Vatika be taken?
Dosage and timing should be confirmed from the product packaging and with a qualified healthcare professional. The supplied directions should not be treated as a personalised regimen.
Q3. Can this product be used for delayed or absent periods?
Menstrual delays or absent periods can have different causes and require appropriate assessment. Do not use this product to induce menstruation without professional guidance.
Share
